Loading asset research
Equillium Inc. Common Stock
EQNasdaq · USD · StocksQuote as of · Exchange session not verified$2.11
-12.81%
Today
EQ
Loading 1D prices…
Market cap
$133.8M
Volume
552.2K
52w high
$3.5452w low
$0.76Company profile
Equillium Inc. Common Stock
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
La Jolla, CA, United States
Employees
14
Fiscal year end
1231
CIK
1746466
Session & valuation
Open$2.46
Previous close$2.42
Day high$2.46
Day low$2.11
30-day avg. volume471.6K
Outstanding shares63.4M
Diluted EPS-$0.39
Latest annual period
P/E (trailing)-5.41
P/E (forward)-9.01
Price / book2.39
Beta1.80
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ADCTADC Therapeutics SA Common Shares | $136.6M | $81.4M | -175.28% | -$1.12 | -4.50% | Buy |
| HURATuHURA Biosciences Inc. Common Stock | $130.6M | $0.00 | — | -$0.63 | +1.23% | Buy |
| INOInovio Pharmaceuticals Inc. Common Stock | $129.2M | $65.3K | -130082.79% | -$1.81 | -2.73% | Buy |
| CNTBConnect Biopharma Holdings Limited Ordinary Shares | $128.5M | $64K | -86687.50% | -$1.00 | -0.97% | Buy |
| KZIAKazia Therapeutics Limited American Depositary Shares | $127.9M | — | — | -$18.90 | +1.63% | Buy |